Tricyclic Antidepressant (TCA)
Pregnancy: Avoid if possible — neonatal withdrawal and anticholinergic effects in neonate. Use lowest effective dose; sertraline preferred.
Amitriptyline
Brand names: Tryptizol, Elavil
Adult dose
Dose: Depression: 75–150mg OD at night initially (start 25–50mg OD); maximum 200mg OD. Neuropathic pain / migraine prophylaxis: 10–25mg at night initially; usual dose 25–75mg ON; maximum 75mg ON. Nocturnal enuresis (off-label): 10–25mg at night.
Route: Oral
Frequency: Once daily at night (sedating — most of dose taken at bedtime)
Max: 200mg OD (depression); 75mg ON (neuropathic pain/migraine — higher doses increase toxicity risk without additional benefit)
At doses used for neuropathic pain and migraine prophylaxis (10–75mg), amitriptyline is not a therapeutic antidepressant dose. Sedation is a useful property for insomnia comorbidity. High toxicity in overdose — cardiotoxicity (QRS widening, VT), anticholinergic toxidrome, and seizures. Low therapeutic index — prescribe cautiously in patients with suicide risk.
Paediatric dose
Route: Oral
Frequency: Once daily at night
Max: 75mg ON
BNFc: Neuropathic pain (2–11 years): 100–500 micrograms/kg ON (max 25mg); (12–17 years): 10mg ON, up to 75mg ON. Nocturnal enuresis (6–10 years): 10–20mg ON; (11–16 years): 25–50mg ON. Not licensed for depression under 18 years. Seek specialist paediatric opinion.
Dose adjustments
Renal
Use with caution in renal impairment — risk of accumulation and CNS toxicity.
Hepatic
Avoid in severe hepatic impairment — impaired metabolism; accumulation and sedation risk.
Clinical pearls
- Overdose antidote: IV sodium bicarbonate is the specific treatment for TCA cardiac toxicity (QRS widening >100ms) — alkalinisation reverses sodium channel blockade. Bolus 1–2 mEq/kg IV, repeat until QRS narrows
- TCA overdose is a medical emergency — even small ingestions in children are potentially fatal; serious toxicity at 10–20mg/kg
- Low-dose amitriptyline (10–30mg ON) is widely used off-label for neuropathic pain, migraine prophylaxis, and IBS — NICE NG59 includes amitriptyline as first-line for neuropathic pain
- Anticholinergic burden: avoid in elderly (Beers Criteria) — risk of delirium, urinary retention, falls, cognitive decline
Contraindications
- Recent MI (within 3 months)
- Arrhythmias, heart block
- Mania (may precipitate)
- Closed-angle glaucoma
- Urinary retention
- MAOIs (within 14 days — risk of severe hypertension / serotonin syndrome)
- Hypersensitivity to amitriptyline or other TCAs
Side effects
- Sedation (useful therapeutically at night)
- Dry mouth, constipation, urinary retention, blurred vision (anticholinergic)
- Orthostatic hypotension (alpha-1 blockade — fall risk in elderly)
- QTc prolongation, heart block (cardiotoxic)
- Weight gain
- Confusion / delirium (elderly)
- Serotonin syndrome (overdose)
- Lowered seizure threshold
Interactions
- MAOIs — contraindicated
- Antiarrhythmics, other QT-prolonging drugs — additive cardiac toxicity
- CNS depressants, alcohol — additive sedation
- Anticholinergic drugs — additive effects (urinary retention, confusion)
- Adrenaline (epinephrine) — amitriptyline blocks noradrenaline reuptake; risk of severe hypertension — avoid felypressin-free local anaesthetic or use with caution
Monitoring
- ECG (QTc) — before starting if cardiac risk factors or dose >100mg
- Blood pressure (orthostatic hypotension — sit-to-stand BP)
- Weight (long-term)
- Anticholinergic side effects review
Reference: BNFc; BNF 90; NICE NG59 (Neuropathic Pain); NICE CG150 (Headaches). Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Drugs
Pathways
- Acute Behavioural Disturbance / Rapid Tranquillisation · RCEM 2022; RCPsych 2022; NICE NG10
- Self-Harm Presentation · NICE NG225 (2022)
- Capacity Assessment (Mental Capacity Act) · MCA 2005; Code of Practice
- Acute Psychosis Management · NICE CG178 2014
- Depression Management · NICE CG90 2022
- Lithium Therapy Monitoring · NICE CG185 / BNF